Pliant Therapeutics, Inc. (PLRX) Misses Q1 EPS by 15c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q1 EPS of ($0.92), $0.15 worse than the analyst estimate of ($0.77).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• Freedom Broker Upgrades Satellogic, Inc. (SATL) to Buy, 'Growth quality is improving'
• Iridium Communications (IRDM) July 50,55 and 60 calls active mid Rocket Lab (RKLB) acquiring
• General Mills (GIS) call put ratio 2.6 calls to 1 put with a focus on July 37.50 calls into quarter results